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Abstract Gold nanoparticles (AuNPs) of 30–40 nm in size has been prepared using
A. hirsutus leaves extract as reducing agent for Au3? ions under microwave irra-
diation from 60 to 360 s. These biocapped AuNPs were effectively conjugated with
activated folic acid (FA, receptor) and chlorambucil (CHL, anticancer drug)
molecules. The formation of AuNPs–FA–CHL was confirmed from different
characterization techniques such as XRD, UV–Visible spectra, FT-IR and TEM
images. The anticancer activity of these bioconjugated AuNPs was tested against
human cancer cell lines (HeLa, RKO and A549) in comparison with normal
epithelial cells (Vero). Unlike AuNPs and CHL alone, AuNPs–FA–CHL showed
high toxicity towards human cancer cells by significantly decreasing the percentage
viability of cells. Furthermore, the amount of drug released was found to be max-
imum at an ideal tumor environment pH 5.3.
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Introduction
Conventionally different types of chemotherapeutic agents [1, 2] are used for the
treatment of cancer for a very long period. High doses of these drugs not only
invade the affected sites but freely move through the circulatory system, affecting
various parts of the body causing major side effects viz., nausea, vomiting, anemia,
decreased appetite, nail discoloration, renal failure etc. The intrinsic toxicity of
classical anticancer drugs, and their lack of accessibility at the tumor site, reduced
intake and rapid elimination of drugs by tumor cells are the major difficulties
associated with treating several types of cancer [3].
Some polymeric micelles and dendrimers are known to significantly increase the
rate of delivery of hydrophobic drugs at the target site [4, 5]. However, they are
found to have some of limitations, for example, limited drug loading capacity.
Therefore innovative nanodevices and nanostructures are being developed for
effective anticancer treatment. Particularly, AuNPs are used due to their biocom-
patibility, easy preparation and their ability to bind with various biomolecules
(receptors and drugs). AuNPs are used for bio-imaging, targeted drug delivery and
photodynamic therapy due to their localized surface plasmon resonance. The AuNPs
have shown increased binding affinity and selectivity when functionalized with
various biomolecules such as antibiotics, proteins, receptors, drugs etc., which helps
in precise targeting of drug to the tumor site [6, 7].
The AuNPs synthesized using plant extracts [8, 9], fungus [10] etc. have
numerous benefits. These AuNPs are biocompatible and highly stable at physio-
logical conditions and are protected/capped by biomolecules/peptides which acts as
natural linkers for drugs, antibodies etc. Jang et al. [11] have shown effective and
sustained delivery of doxorubicin from dextran-coated AuNPs to HeLa cell lines.
Tomuleasa et al. [12] have synthesized AuNPs-L-aspartate nanostructure and then
non-covalently conjugated to cisplatin and capecitabine. These particles are found
to reduce cellular proliferation rate in hepatocellular carcinoma (HCC). Gibson
et al. [13] have synthesized 2 nm AuNPs covalently attached to chemotherapeutic
drug paclitaxel. It is well known that, CHL is one of the important chemotherapeutic
drugs used for the treatment of cancer. It is an alkylating agent which reduces the
cell proliferation by inhibiting the DNA replication [14]. The folic acid (FA) is used
as a navigational molecule attached to drug [15]. FA conjugated NPs have been
found to target cancer cells, which over express folate receptors on their surfaces
due to their huge requirement for FA. Conjugation of nanoparticles with FA will
result in effective targeting of NPs leading to synaptic and controlled release of drug
at tumor site, which reduces its adverse effect on nearby healthy cells. Later these
NPs can enter cell via receptor mediated endocytosis [16]. There are many reports
where CHL is used as an effective anti-cancer drug; but has failed as active
targeting at the tumor site [17, 18]. Hence, this study has focused on the formation
of AuNPs–FA–CHL complex as active targeted cancer agent; which minimizes the
amount of drug required for treatment of cancer; and also reduces the adverse effect
on the healthy cell. In this study, we report the formation of AuNPs using A.
hirsutus leaves extract as reducing agent. These NPs are conjugated with FA as
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linking/anchoring molecule and CHL drug. The anticancer activity of these nano-
vehicles is studied against different cell lines.
Materials and Methods
Materials
Gold aurochlorate, dimethyl sulfoxide (DMSO) and propanol were obtained from
Merck Chemicals Ltd., Mumbai, India. CHL, FA, 3-(4,5-dimethyl thiazol-2-yl)-5-
diphenyl tetrazolium bromide (MTT), fetal bovine serum (FBS), phosphate buffered
saline (PBS), Dulbecco’s modified eagle’s medium (DMEM) and trypsin were
obtained from Sigma Aldrich Co, St Louis, USA. EDTA, glucose and antibiotics
were from Hi-Media Laboratories Ltd., Mumbai, India. The normal (Vero) and
cancer cell lines viz., HeLa, RKO and A549 were procured from National Centre for
Cell Sciences (NCCS) Pune, India. All the experiments were carried out using
distilled water.
Preparation of Aqueous A. hirsutus Leaves Extract
A. hirsutus plant (available in Western ghat region of Karnataka) leaves were
collected and cleaned using distilled water and cut into small pieces. A 10 g of these
leaves were soaked in 200 ml of distilled water and kept for microwave irradiation
(ONIDA, 2.45 GHz) for about 180 s to extract the biomolecules present in the
leaves. The fibrous impurities were filtered in hot condition using 0.2 lm membrane
filter paper and stored at 4 C for further experimental requirements.
Synthesis of AuNPs
A 10 ml of leaves extract was added to 50 ml of 1 mM HAuCl4 and the mixture was
microwave irradiated at a fixed frequency of 2.45 GHz at regular intervals of time
(the experiment was done in duplicate for reproducibility). As the reaction proceeds,
the reaction mixture changed to light yellow and then to dark brown indicating the
formation of AuNPs, and it was recorded periodically using UV–Vis spectrum
(Shimadzu, 1650-PC) to observe the surface plasmon resonance peak. After about
360 s, there was no further increase in the absorption peak and also any change in
color. The colloidal solution thus obtained was centrifuged at 10,000 rpm for
15 min and washed several times with distilled water. The AuNPs were dried in
vacuum oven at 80 C for about 12 h to obtain the product in powdered form for
further studies.
Conjugation of Activated FA and CHL to AuNPs
FA (0.25 g) was dissolved in DMSO using sonicator. To this solution, n-hydroxy
succinimide (NHS, 0.225 g) and dicarboxy aminocarbodiimide (DCC, 0.125 g)
were added (FA/NHS/DCC molar ratio 2:2:1) [19]. It was stirred continuously for
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about 12 h in an argon atmosphere at room temperature (RT). The activated FA in
the form of colloidal mixture was collected by filtration. It was dried at RT. A 0.1 g
of this powder and 500 mg of AuNPs were added to 20 ml of DMSO and stirred
continuously for about 30 h under argon atmosphere to obtain AuNPs–FA complex.
This complex was collected by filtration and dried at RT. Further, equimolar
amounts of CHL (0.25 mM) and AuNPs–FA (0.25 mM) treated with using N N’-
carbonyldiimidazole (CDI) in presence of imidazole hydrochloric acid. The molar
ratio of AuNPs–FA/CHL/CDI was 1:1:2. The mixture was stirred continuously at
RT for about 24 h. The resultant AuNPs–FA–CHL conjugate was subjected for
dialysis for 24 h to remove the excess reactants.
Drug Releasing Studies
Amount of drug released was studied by adding 5 ml of AuNPs–FA–CHL complex
to three different porous dialysis tubes which were placed separately in a beaker
containing 50 ml of phosphate buffer solution maintained at different pH (5.3, 6.8
and 7.2) and was continuously stirred at 100 rpm. The entire system was kept in an
incubator at 37 C. To measure the drug release content, 1 ml samples were
periodically removed and replaced with an equivalent volume of phosphate buffer
solution. The amount of drug released was monitored by recording UV–Vis
spectrophotometer at 485 nm. The experiments were done in triplicate and mean
(X) values were calculated.
Characterization Techniques
The X-ray diffraction (XRD) pattern of AuNPs was recorded by Siemens X-ray
diffractometer, Japan with Cu Ka radiation (k = 0.15406 nm) at a scanning rate of
2/min and 2h ranging from 30 to 80. Transmission electron microscopy (TEM,
PHILIPS CM-200) was used to observe the morphology of AuNPs. Fourier
transform infrared (FT-IR, Bruker-TENSOR 27) spectra were recorded in KBr
pellet to known the type of phytochemicals adsorbed/anchored on the surface of
AuNPs with activated FA and anticancer drug.
Cytotoxicity Studies
The cytotoxic effect of AuNPs, CHL and AuNPs–FA–CHL conjugate were tested
against HeLa, RKO and A549 cells by MTT assay. The principle involved is the
cleavage of tetrazolium salt of MTT into a blue colored product (formazan) by
mitochondrial enzyme succinate dehydrogenase [20]. The assay depends both on the
number of cells present and on the mitochondrial activity per cell, as the dead cells
or their products do not reduce tetrazolium.
For preparation of test solutions, the weighed samples viz., AuNPs, CHL,
AuNPs–FA and AuNPs–FA–CHL were dissolved in DMSO to obtain different
doses levels, 0–250 mg/ml. To each well of the 96 well microtitre plate, 0.1 ml of
the diluted cancer cell suspension (approximately 10,000 cells) was added. After
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24 h, 100 ll of test samples were added to the microtitre plates. The plates were
then incubated at 37 C for 3 days in 5 % CO2 atmosphere. After 72 h, the drug
solutions in the wells were discarded and 50 ll of MTT in PBS was added to each
well. The plates were gently shaken and incubated for 3 h at 37 C in 5 % CO2
atmosphere. The supernatant was removed and 100 ll of propanol was added and
the plates were gently shaken to solubilize the formed formazan. The absorbance
was measured using a micro plate reader at 540 nm. The percentage growth
inhibition was calculated using the following formula and concentration of test drug
needed to inhibit cell growth by 50 % (IC50) values is generated from the dose–
response curves for each cell line. The % of cell viability reported here are found to
carry a maximum of ±5 % deviation.
%Growth Inhibition ¼ 100 Mean OD of individual test group
Mean OD of control group
 100
 
Results and Discussion
Synthesis of AuNPs
AuNPs were synthesized by using aqueous leaves extract of A. hirsutus, which has a
rich source of phytochemicals such as alkaloids, flavonoids, saponins, terpenoids etc.,
traditionally used as antibacterial and anti-inflammatory agent [21]. These phyto-
chemicals acts as both reducing and capping agent for the formation of AuNPs. The
formation of AuNPs was monitored using UV–Vis spectra, Fig. 1, these noble metal
nanoparticles exhibit strong optical extinction coefficient at visible and near-infrared
Fig. 1 UV–Vis spectra of the reaction mixture showing the SPR peak at 540 nm
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region due to localized surface plasmon resonance (LSPR, kmax) of their free
electrons, upon excitation by an electromagnetic field [22, 23]. As the reaction
mixture (HAuCl4 ? plant leaf extract) was irradiated at regular intervals of time in
microwave oven, the color was found to change from light–yellow (t = 20 s) to
yellowish–brown (t = 120 s) and then to dark–brown (t = 420 s), indicating the
formation of AuNPs. The optical density of the reaction mixture increased in response
to the irradiation time observed up to 360 s. The kmax decreased from 550 to 540 nm
(blue shift) is mainly due to increase in particle size [24].
Crystallite size and structure of AuNPs was examined using XRD pattern,
Fig. 2a. The four distinct diffraction peaks of the 2h values of 38.7, 44.3, 65 and
77.5 can be assigned to (111), (200), (220) and (311) planes respectively;
indicating that the AuNPs are fcc structured (JCPDS 89-3722) [25]. The crystallite
mean size of AuNPs was found to be 32 nm using the Debye–Scherrer’s equation,
d = Kk/bcosh where, K-shape factor between 0.9 and 1.1, k-incident X-ray
wavelength (Cu Ka = 0.1542 nm), b-full width half maximum in radians of the
prominent line (111) and h-position of that line in the pattern. The TEM image
(Fig. 2b, c) shows the near spherical nature of the particles with the sizes ranging
from 5 to 40 nm. It is also clear that the nanoparticles are well separated showing no
agglomeration. The SAED image (Fig. 2d) confirms the fcc structure of AuNPs.
Optimum efficiency of delivery of the AuNPs into the pulmonary system can be
achieved for nanoparticles of diameter %40 nm [26].
Fig. 2 a XRD pattern of AuNPs. b, c TEM images of AuNPs in different magnifications d SEAD pattern
of AuNPs
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Conjugation of AuNPs with Activated FA and CHL
The UV–Vis spectra of AuNPs, activated FA, CHL and AuNPs–FA–CHL are given
in Fig. 3. The SPR peaks for AuNPs (*530 nm), activated FA (*282 nm) and
CHL (*485 nm) can be seen clearly. For AuNPs–FA–CHL complex, the SPRs
shifted to 570, 350 and 450 nm, respectively. This is a clear indication of AuNPs
conjugation with FA and CHL.
As shown in Fig. 4, the FT-IR spectra of plant extract shows the presence of
polyphenols, flavonoids etc. O–H stretching shows peak at 3431 cm-1. A peak at
2422 cm-1 corresponds to aldehydic C–H stretching; weaker band at 1667 cm-1 is
ascribed to ketone and ester group [27, 28]. The peak at 1520 cm-1 corresponds to
germinal methyl group and a peak near 1120 cm-1 is assigned to C–N stretching
vibrations [29]. When we compare this with the FT-IR spectra of AuNPs
synthesized by same plant extract, there is a shift in IR bands from 1667 to 1573,
1520 to 1383 and 1120 to 1250 cm-1. This indicates phytochemicals such as
polyphenols, flavonoids and terpenoids are involved in reduction of Au3? to AuNPs.
The peaks at 1713 and 1645 cm-1 for activated FA correspond to –COOH and
–NH2 stretching, respectively. The peak at 3488 cm
-1 was assigned to –OH group
of FA. In the case of AuNPs–FA, the absence of 1713 cm-1 is due to the interaction
of carboxylic group of FA with AuNPs. The emergence of a strong peak at
1504 cm-1 corresponds to asymmetric bending vibrations of –CO and stretching of
primary amines –NH– suggesting that the FA must be anchored to AuNPs via an
amide linkage [19], Although, the FA has both a and c-carboxylic acids, c-
carboxylic acid is activated preferentially due to its higher reactivity [30, 31]. The
FT-IR spectra of CHL complex exhibits a prominent peak at 1702 cm-1 which
corresponds to free carboxylic acids. For AuNPs–FA–CHL complex, appearance of
Fig. 3 UV–Vis spectra of AuNPs before and after conjugation with FA and CHL. For comparison, the
spectra of activated folate and CHL are also shown
Conjugation of Au Nanoparticles with Chlorambucil...
123
a strong peak at 1598 cm-1 corresponds to asymmetric bending vibrations of –CO
and stretching of primary amines –NH–. This indicates the interaction of AuNPs–
FA–CHL complex via peptide linkage [32].
The TEM images of AuNPs–FA–CHL are shown in Fig. 5. In comparison with
Fig. 2b, there are no significant differences in morphology of AuNPs before and
after conjugation of the drug. However, a thin coating of scum surrounded on
AuNPs is clearly seen due to bio-capping of plant based molecules and conjugated
FA and CHL. In fact the presence of plant phytochemicals on AuNPs enhances its
antimicrobial activity and also facilitates the conjugation of anticancer drugs.
Fig. 4 FT-IR spectra of A.
hirsutus extract, AuNPs,
activated FA, AuNPs–FA, CHL
and AuNPs–FA–CHL
Fig. 5 TEM images of AuNPs–FA–CHL
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The cytotoxic effects of AuNPs modified with FA and CHL were tested against
vero and different cell lines. The effect of AuNPs, free CHL and AuNPs–FA–CHL on
vero and HeLa, RKO and A549 cells are compared in Fig. 6 at different incubation
periods (24–72 h) as a function of different dose levels. It can be observed that %
viability of cells decreases with increasing dose i.e., 50–250 lg/ml and increasing
incubation period 24–72 h. Further, at lower concentration (50 lg/ml) the percentage
of cell viability of AuNPs is found to be *80 % for both normal and cancer cells.
Though, a steady decrease in the viability of cells with increasing concentration of
AuNPs is also observed. At higher dose of 250 lg/ml, the viability of vero, HeLa,
Fig. 6 Cytotoxicity of AuNPs, CHL and AuNPs–FA–CHL on different cancer cell lines as a function of
dose levels. (The F values, P values and d.f are shown in Tables 2, 3, and 4)
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RKO and A549 cells dropped to 68.8, 58.2, 61.1, and 58.5 % respectively after 72 h of
treatment. The IC50 values and % inhibition of cell proliferation of AuNPs is given in
Table 1. This high cytotoxicity of AuNPs on human cancer cells depends on bio-
capped organic moiety and morphology of nanoparticles [33]. Cancer cells (as
compared to vero cells) carries disordered endothelial cells because of which, there
will be more accumulation of nanoparticles at tumor site, which can easily penetrate
inside the cancer cells leading to high cytotoxic effect as compared to the normal vero
cells [34]. On the other hand vero cells showed good biocompatibility towards
AuNPs; mainly due to the presence of cell growth boosting factors of the extract from
A. hirsutus, which carries high concentration of biomolecules such as polyphenols,
terpenoids, alkaloids etc. [21, 35]. It means there is a preferential targeting of cancer
cells by these bioconjugated AuNPs.
Further, we have tested the cytotoxic effect of CHL and AuNPs–FA–CHL on
normal and cancer cells and it was found to be considerably high at all the
concentrations (50–250 lg/ml). For instance; at higher dose of 250 lg/ml CHL, the
cell viability is found to be *50 % for normal cells and *32 % for cancer cells.
The IC50 values of CHL are found to be, 180 lg/ml for vero, 150 lg/ml for HeLa,
155 lg/ml for RKO, and 158 lg/ml for A549 cell lines, upon 48 h exposures. These
results signify CHL as one of the potent chemotherapeutic drug. Comparing
cytotoxic effect of AuNPs–FA–CHL with CHL and AuNPs alone, the toxicity effect
of AuNPs–FA–CHL complex was found to be very high. The cell viability was
found to be *50 % for normal cells, *20 % for cancer cells at 200 lg/ml
concentration and *10 % for cancer cells at 250 lg/ml concentration of AuNPs–
FA–CHL. A sudden decrease in the percentage of viability of cells at higher
concentration was observed. The IC50 value of AuNPs–FA–CHL on normal and
cancer cells was found to be 170 and 130 lg/ml respectively. Thus, AuNPs–FA–
CHL is highly potent when compared to CHL or AuNPs alone; even at lower
concentrations. The CHL–tethered nanoparticles demonstrated a significantly better
cytotoxicity, than CHL alone; on all cell lines and relatively biocompatibility for
normal cells; probably due to, the impact of potential targeting on cancer cells.
Good number of researches has also explored similar biocompatibility of AuNPs
[36, 37]. However, the cytotoxicity of AuNPs on cancer cells mainly depends on
their size and shape of nanoparticles, as well as on the type of drug [38, 39].
Brown et al. [40] have reported conjugating anticancer drug oxaliplatin to AuNPs
for improved drug delivery. And this complex shows high cytotoxicity towards lung
Table 1 Growth-inhibitory effect of AuNPs–FA–CHL after 48 h
Samples Inhibitory effect on cell lines (IC50)
Vero HeLa RKO A-549
AuNPs 220 lg/ml (50.06 %) 210 lg/ml (53.70 %) 210 lg/ml (52.50 %) 205 lg/ml (51.70 %)
CHL 180 lg/ml (48.75 %) 150 lg/ml (54.55 %) 155 lg/ml (53.60 %) 158 lg/ml (54.22 %)
AuNPs–
FA–
CHL
170 lg/ml (47.25 %) 130 lg/ml (58.60 %) 132 lg/ml (58.32 %) 133 lg/ml (58.32 %)
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epithelial cancer cell line A549 and on colon cancer cell lines HCT116, RKO. Dong
N Heo et al. [41] in their study described AuNPs surface-functionalized with PEG,
biotin, paclitaxel (PTX), which can be useful as a theranostic agent for cancer
therapy against cancer cells such as HeLa and MG63. However, the detailed studies
are required to understand the process of endocytosis and molecular mechanism of
nanoparticles on cancer cells.
Jaganathan et al. [42] in their study synthesized silver nanoparticles (EW–AgNP)
using Eudrilus eugeniae earthworms as reducing and stabilizing agents. The
synthesized nanoparticles were characterized using UV–vis spectrophotometer,
FTIR and FESEM. The cytotoxicity of EW-AgNP were tested against HepG2 cells
by MTT assay, which showed decreased cell proliferation rate (in dose dependent
manner). It also exhibited impending toxicity on Plasmodium parasites and
mosquito vectors.
Kadarkarai Murugan et al. [43] biofabricated silver nanoparticles (AgNP) using
plant extract of Azadirachta indica as reducing and stabilizing agent. AgNP were
then characterized using UV–vis spectrophotometry, SEM, EDX, XRD and FTIR
spectroscopy. The AgNP was found to be toxic against Anopheles stephensi larvae
and pupae; LC50 of AgNP is found to be 3.9 ppm (larva I), which is very less when
Table 2 Average % viability of different cell lines against various concentration of AuNPs
Concentration of
AuNPs in lg
Cancer cell lines/AuNPs
Vero/AuNPs Hela/AuNPs RKO/AuNPs A-549/AuNPs Sum of
rowsAvg. % viability Avg. % viability Avg. % viability Avg. % viability
50 80.33 79.33 78.33 74.00 312.00
100 78.67 73.00 71.00 69.00 291.67
150 77.33 69.33 69.00 67.00 282.67
200 68.33 62.00 68.00 59.33 257.67
250 66.33 59.33 56.00 57.00 238.67
Sum of columns 371.00 343.00 342.33 326.33
(a) Summary values of variances
Total SS 1091.42
SS between column treatment 206.76
SS between row treatment 828.59
SS residual or error 56.08
(b) The ANNOVA table (two way ANNOVA)
Source of variance SS d.f MS F ratio 5 % F limit
(or the table values
Result
Between columns 206.76 (4 - 1) = 3 68.92 14.75 F(3,12) = 3.49 H0 rejected
Between rows 828.59 (5 - 1) = 4 207.15 44.33 F(4,12) = 3.26 H0 rejected
Residual or error 56.08 3 * 4 = 12 4.67
Source Primary data, data recorded at different time periods i.e. 24, 48 and 72 h and the average % age
viability data is used for the purpose of analysis
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compared to that of plant extract 232.8 ppm (larva I). And In vitro, AgNP is also
found to be toxic to chloroquine-resistant Plasmodium falciparum parasites.
Giovanni Benelli et al. [44] in their study exhibit the relationship between cancer
and mosquito-born diseases, with special reference to malaria. The study
hypothesized that; Anopheles vectors may transmit obscure viruses linked with
cancer development. Further, many studies have explored the probability of the
hamster reticulum cell sarcoma being transmitted through the bites of Aedes aegypti
which transforms healthy cells into tumor cells. These studies have found that
Mosquito bites may influence human metabolic pathways following different
mechanisms, leading to other viral infections and/oncogenesis.
Testing the hypothesis; using ANOVA the following results are observed;
From Table 2a, b; the variance reported in terms of % age viability among
different cell lines and at different concentration of AuNPs in lg is statistically
significant; as the derived value of F is greater than F statistical values derived at
5 % level of significance and H0 is rejected.
From Table 3a, b; the variance reported in terms of % age viability among
different cell lines and at different concentration of CHL in lg is statistically
Table 3 Average % viability of different cell lines against various concentration of CHL
Concentration
of CHL in lg
Cancer cell lines/CHL
Vero/CHL Hela/CHL RKO/CHL A-549/CHL Sum of
rowsAvg. % viability Avg. % viability Avg. % viability Avg. % viability
50 66.67 67.33 59.00 59.00 252.00
100 62.00 59.00 51.00 58.00 230.00
150 58.00 57.00 47.00 52.00 214.00
200 52.00 49.33 31.00 44.00 176.33
250 49.00 43.33 19.00 32.00 143.33
Sum of columns 287.67 276.00 207.00 245.00
(a) Summary values of variances
Total SS 2875.84
SS between column treatment 781.48
SS between row treatment 1880.53
SS residual or error 213.82
(b) The ANNOVA table (two way ANNOVA)
Source of variance SS d.f MS F ratio 5 % F limit
(or the table values
Result
Between columns 781.48 (4 - 1) = 3 260.49 14.62 F(3,12) = 3.49 H0 rejected
Between rows 1880.53 (5 - 1) = 4 470.13 26.38 F(4,12) = 3.26 H0 rejected
Residual or error 213.82 3 * 4 = 12 17.82
Source Primary data, data recorded at different time periods i.e. 24, 48 and 72 h and the average % age
viability data is used for the purpose of analysis
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significant; as the derived value of F is greater than F statistical values derived at
5 % level of significance and H0 is rejected.
From Table 4a, b; the variance reported in terms of % age viability among
different cell lines and at different concentration of AuNPs–FA–CHL in lg is
statistically significant; as the derived value of F is greater than F statistical values
derived at 5 % level of significance and H0 is rejected.
The most important function of AuNPs–FA–CHL is; the controlled release of drug
in an ideal tumor environment. In this study, (Fig. 7) we have tested the drug release
profile; at different conditions, pH 7.2 (physiological pH) and 5.4 (pH of the tumor
environment). The rate of drug release was found to be fast at pH 5.4 and relatively
slower at pH 6.7 and pH 7.2. This type of mechanism is said to act as a dual pronged
tool; for treatment of cancer. Immediately, after the injection of the AuNPs–FA–
CHL conjugate; it is found to first interact with blood components, at physiological
pH (7.2). At this pH, the amount of drug release is relatively slow (most of CHL
remains anchored at the surface of AuNPs). Once these conjugates, enter into the
cancer cells via an endocytic pathway; the amount of drug release will significantly
Table 4 Average % viability of different cell lines against various concentration of AuNPs–FA–CHL
Concentration of
AuNPs–FA–
CHL
in lg
Cancer cell lines/AuNPs–FA–CHL
Vero/AuNPs–
FA–CHL
Hela/AuNPs–
FA–CHL
RKO/AuNPs–
FA–CHL
A-549/AuNPs–
FA–CHL
Sum of
rows
Avg. % viability Avg. % viability Avg. % viability Avg. % viability
50 64.00 53.33 57.00 56.00 230.33
100 59.67 44.00 47.00 48.00 198.67
150 52.00 29.00 29.00 36.00 146.00
200 48.67 18.00 21.33 20.00 108.00
250 45.33 9.33 15.00 19.00 88.67
Sum of columns 269.67 153.67 169.33 179.00 771.67
(a) Summary values of variances
Total SS 5518.86
SS between column treatment 1636.19
SS between row treatment 3567.44
SS residual or error 315.22
(b) The ANNOVA table (two way ANNOVA)
Source of variance SS d.f MS F ratio 5 % F limit
(or the table values
Result
Between columns 1636.19 (4 - 1) = 3 545.40 20.76 F(3,12) = 3.49 H0 rejected
Between rows 3567.44 (5 - 1) = 4 891.86 33.95 F(4,12) = 3.26 H0 rejected
Residual or error 315.22 3 * 4 = 12 26.27
Source Primary data, data recorded at different time periods i.e. 24, 48 and 72 h and the average % age
viability data is used for the purpose of analysis
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increases (the majority tumor environments have been found to be acidic pH 4.5–6.5)
depending on the nature of tumor. In an ideal tumor environment, the delivery of
drug from nano-vehicles is mainly dependent on its pH.
Conclusion
A spherical shaped AuNPs have been successfully synthesized by using A. hirsutus
leaves extract as a bioreducing agent. These AuNPs were found to be coated/
adsorbed with biomolecules from plant extract, and such a bio-capping was helpful
for further conjugation with drug. Activated FA and CHL were effectively
conjugated to AuNPs forming AuNPs–FA–CHL. Such a drug delivery complex,
AuNPs–FA–CHL is tested here against normal epithelial cells and human cancer
cells (HeLa, RKO and A549); which when compared to AuNPs and CHL alone, the
drug conjugated AuNPs has shown a high toxicity towards human cancer cells by
significantly decreasing the percentage viability of cells. At the same time, it shows
high toxicity towards HeLa cell lines compared to other cell lines. Further the
amount of drug released has found to be maximum at pH 5.3 (pH of an ideal tumor
environment). In summary, we have developed an eco-friendly, bio-compatible drug
delivery complex. Further studies (in vivo) are required to understand the exact
mechanism of action of drug on cancer cells.
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